FORM Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41M Buy
9,572
+1,342
+16% +$289K 0.26% 18
2026
Q1
$1.79M Sell
8,230
-388
-5% -$86.1K 0.21% 20
2025
Q4
$1.97M Buy
+8,618
New +$1.96M 0.23% 19
2025
Q2
$1.65M Sell
8,863
-146
-2% -$27.1K 0.2% 23
2025
Q1
$1.89M Buy
+9,009
New +$1.75M 0.26% 21

Other funds holding ABBV

FORM Wealth Advisors's ABBV Position: Q2 2026 in Review

FORM Wealth Advisors increased its AbbVie (ABBV) stake by 16% in Q2 2026, buying an estimated $289K and bringing the position to 9,572 shares worth $2.41M. The position accounts for 0.26% of the portfolio, ranked #18.

FORM Wealth Advisors first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • FORM Wealth Advisors held 9,572 shares of AbbVie worth $2.41M as of Q2 2026.
  • FORM Wealth Advisors bought 1,342 AbbVie shares in Q2 2026, an estimated $289K.
  • AbbVie made up 0.26% of FORM Wealth Advisors's portfolio in Q2 2026, its #18 holding.
  • FORM Wealth Advisors first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on FORM Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.